| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/05/2008 | US20080131900 Variants of alpha-fetoprotein coding and expression sequences |
| 06/05/2008 | US20080131889 Novel human genes and gene expression products: II |
| 06/05/2008 | US20080131884 Tubulin Mutation Diagnostic |
| 06/05/2008 | US20080131882 Procedure for Structural Characterization of a Recombinant Polylonal Protein or a Polyclonal Cell Line |
| 06/05/2008 | US20080131881 Using monospecific immunoglobulins as diagnostic/prognostic tool in detecting nervous system disorders |
| 06/05/2008 | US20080131453 Campylobacter Jejuni Outer Membrane Protein Immunogenic Composition |
| 06/05/2008 | US20080131448 Using interleukin receptor as tool in treatment cell proliferative disorders; antitumor agents |
| 06/05/2008 | US20080131447 Using alkyl hydroperoxide reductase as tool in developing vaccines to prevent and treat microorganismal infection; immunotherapy |
| 06/05/2008 | US20080131443 Method and composition for reconforming multi-epitopic antigens to intiate an immune response |
| 06/05/2008 | US20080131442 Polymerase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/05/2008 | US20080131440 Using ultra-low doses of monoconal, polycloncal or natural antibodies to treat infectious disease |
| 06/05/2008 | US20080131438 Antibodies to non-functional p2x7 receptor |
| 06/05/2008 | US20080131436 Polypeptide Compounds for Inhibiting Angiogenesis and Tumor Growth |
| 06/05/2008 | US20080131435 Recombinant immunoglobulins to mediate cytotoxicity and treat cell proliferative disorders; immunotherapy |
| 06/05/2008 | US20080131434 Compositions and methods for diagnosing and treating cancer |
| 06/05/2008 | US20080131433 Fc Receptor Homolog Antibodies And Uses Thereof |
| 06/05/2008 | US20080131431 CD47 related compositions and methods for treating immunological diseases and disorders |
| 06/05/2008 | US20080131429 Reducing human breast or prostate tumors using monoclonal antibodies; immunotherapeutics; tissue targeted therapy; antitumor agents |
| 06/05/2008 | US20080131428 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 06/05/2008 | US20080131424 Method of treatment and agents useful for same |
| 06/05/2008 | US20080131423 Triggering receptors expressed on myeloid cells (TREMs) specific immunoglobulin for use in prevention and treatment of blood coagulation disorders |
| 06/05/2008 | US20080131422 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 06/05/2008 | US20080131421 Neisserial antigens |
| 06/05/2008 | US20080131411 Using vector transformation comprising wildtype fkhsf gene as therapeutic in prevention and treatment of skin and kidney disorders |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/05/2008 | US20080131373 Fab proteins; anticancer agents; immunoglobulins; gene expression inhibition; kits |
| 06/05/2008 | US20080131370 For prophylaxis or treatment of apoptosis or inflammation-associated disease, diabetes, or chronic obstructive pulmonary disease |
| 06/05/2008 | US20080131365 Cancerous disease modifying antibodies |
| 06/05/2008 | DE10107186B4 Neue Form des PHGPx-Proteins als diagnostischer Marker bei männlicher Infertilität A new form of PHGPx protein as a diagnostic marker for male infertility |
| 06/05/2008 | CA2671264A1 Improved immunoglobulin libraries |
| 06/05/2008 | CA2670696A1 Ovr110 antibody compositions and methods of use |
| 06/05/2008 | CA2670583A1 Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor |
| 06/05/2008 | CA2670445A1 Binding members for interleukin-6 |
| 06/05/2008 | CA2668800A1 Tes7 and antibodies that bind thereto |
| 06/05/2008 | CA2666549A1 Il-17a/f heterodimeric polypeptides and therapeutic uses thereof |
| 06/05/2008 | CA2664809A1 Soybean gene for resistance to aphis glycines |
| 06/04/2008 | EP1927665A2 Methods and kits for diagnosing and treating b-Cell chronic lymphocytic leukemia (B-CLL) |
| 06/04/2008 | EP1927600A1 Homogeneous preparations of IL-28 and IL-29 |
| 06/04/2008 | EP1927362A2 Alphavbeta3integrin as a predictor of endometriosis |
| 06/04/2008 | EP1926752A2 Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| 06/04/2008 | EP1926751A1 Method for generating f(ab')2 antibody fragments |
| 06/04/2008 | EP1926750A2 Biological materials and uses thereof |
| 06/04/2008 | EP1592777A4 A method for generating high affinity antibodies |
| 06/04/2008 | EP1493033B1 Use of sc6 for diagnosis and treatment of breast carcinoma |
| 06/04/2008 | EP1463754B1 Cystine-knot fold protein |
| 06/04/2008 | EP1308168B1 Novel remedies for cancer |
| 06/04/2008 | EP1185658B1 Novel compounds from moraxella catarrhalis |
| 06/04/2008 | EP1151304B9 METHOD OF IDENTIFYING N-TERMINAL proBNP |
| 06/04/2008 | EP1137436B1 Stimulation of T-cells against self antigens using CTLA-4 blocking agents |
| 06/04/2008 | EP1028749B1 Enterococcus antigens and vaccines |
| 06/04/2008 | EP0920505B1 Mammalian cell surface antigens; related reagents |
| 06/04/2008 | CN101193917A Anti-MAdCAM antibody compositions |
| 06/04/2008 | CN101193916A Anti-integrin immunoconjugates, methods and uses |
| 06/04/2008 | CN101193915A Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 06/04/2008 | CN101193914A Antibodies directed against amyloid-beta peptide and methods using same |
| 06/04/2008 | CN101193912A Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof |
| 06/04/2008 | CN100392080C Variable region of light chain and heavy chain genes of anti-KDR monoclonal antibody and its use |
| 06/04/2008 | CN100391980C Antitumour multitarget composite antigen, its coding gene and application |
| 06/04/2008 | CN100391978C Recombinant anti-CD4 antibodies for human therapy |
| 06/04/2008 | CN100391977C Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
| 06/04/2008 | CN100391976C High efficiency low poison immune toxin and its preparation method and application |
| 06/04/2008 | CN100391975C Human source anti- tetanus exotoxin antibody and preparation method and use thereof |
| 06/04/2008 | CN100391973C Isolated dendritic cell membrane protein genes |
| 06/04/2008 | CN100391972C Corticotropin releasing factor receptor 2 agonists |
| 06/04/2008 | CN100391537C Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B |
| 06/04/2008 | CN100391469C Remedies for hepatitis C |
| 06/04/2008 | CA2610295A1 Gender selection with the use of antibodies |
| 06/04/2008 | CA2568512A1 Gender selection with the use of antibodies |
| 06/03/2008 | US7381817 LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus |
| 06/03/2008 | US7381803 Humanized antibodies against CD3 |
| 06/03/2008 | US7381802 Human antibodies that specifically recognize the toxin Cn2 from Centruroides noxius scorpion venom |
| 06/03/2008 | US7381801 Chimerized GM-CSF antibodies |
| 06/03/2008 | US7381800 Antibodies to HBIMF63 polypeptide |
| 06/03/2008 | US7381799 Compositions and methods for inhibiting angiogenesis |
| 06/03/2008 | US7381798 binds to 2,3,4,7,8-pentachlorodibenzofuran; expression vectors; simple, rapid and sensitive |
| 06/03/2008 | US7381794 Dimeric fusion proteins and materials and methods for producing them |
| 06/03/2008 | US7381710 Nucleic acid comprising a sequence encoding promyelocytic leukemia retinoic acid receptor alpha and a non-immunosuppressive inducer of tumor cell apoptosis which is arsenic; all-trans, 9-cis or 13-cis retinoic acid; or 4 allopurinol-l-ribonucleoside |
| 06/03/2008 | US7381561 can initiate neurospheres; comprises contacting with monoclonal antibodies and detecting binding; solid phase synthesis; |
| 06/03/2008 | US7381560 Administering a chimeric anti-CD20 antibody; hybridomas; monoclonal antibodies |
| 06/03/2008 | US7381534 Immunoglobulin binding immunogenic polypeptide of given sequence; test kits for allergy detection |
| 06/03/2008 | US7381531 Apparatus which utilizes a complex of an anti-cocaine aptamer and diethylthiotricarbocyanine dyes to detect cocaine in solution; drug testing; calorimetric sensor |
| 06/03/2008 | US7381528 Methods for detection of mutations in myostatin variants |
| 06/03/2008 | US7381414 Mycoplasma vaccine, method of making, and application thereof |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381411 Preventing influenza virus cell binding; schizophrenia; diagnosing chronic viral disease associated with cancer development |
| 06/03/2008 | US7381410 Monoclonal antibodies that bind to epitope and inhibit clustering or phosphorylation between EphB4 and Ephrin B2 |
| 06/03/2008 | US7381409 Immunoglobulin specific to transforming growth factor binding protein for use as tool in prevention and treatment of osteoporosis and bone disorders |
| 06/03/2008 | US7381408 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 06/03/2008 | CA2671875A1 Analytical method for analyzing c-terminus truncation |
| 06/03/2008 | CA2261018C Treatment and diagnosis of cancer |
| 06/03/2008 | CA2243633C Isolated polypeptide for the skin and its use |
| 06/03/2008 | CA2220563C Protein production in transgenic alfalfa plants |
| 06/03/2008 | CA2186269C Wound healing |
| 06/03/2008 | CA2106978C Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 05/29/2008 | WO2008064181A2 Prime boost canine leishmania vaccine |
| 05/29/2008 | WO2008064094A2 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/29/2008 | WO2008063932A2 Method for treating age-related macular degeneration |
| 05/29/2008 | WO2008063898A2 Methods of treating idiopathic thrombocytopenia purpura using a gm-csf antagonist |
| 05/29/2008 | WO2008063776A2 Antibodies to lymphotoxin-alpha |
| 05/29/2008 | WO2008063771A2 Anti-cd20 antibodies and methods of use |